You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hedgehog

Showing 1 - 25 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Basal Cell Carcinoma Trial in Zürich (Cemiplimab Injection [Libtayo])

Recruiting
  • Basal Cell Carcinoma
  • Cemiplimab Injection [Libtayo]
  • Zürich, Switzerland
    University Hospital Zurich, Clinic of Dermatology
Nov 3, 2022

Esophageal Cancer Trial in Dallas (Itraconazole)

Active, not recruiting
  • Esophageal Cancer
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

Recruiting
  • Basal Cell Carcinoma
  • +10 more
  • Nijmegen, Gelderland, Netherlands
  • +7 more
Jul 14, 2022

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Santiago De Compostela, A Coruña, Spain
  • +5 more
Dec 5, 2022

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma Trial in France (Laboratory

Active, not recruiting
Has Results
  • Clear Cell Chondrosarcoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Bordeaux, France
  • +5 more
Sep 20, 2022

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Sclerodermoid Chronic GVHD (Disorder) Trial in Spain (Glasdegib)

Active, not recruiting
  • Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
  • Barcelona, Spain
  • +5 more
Mar 16, 2022

Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)

Active, not recruiting
Has Results
  • Carcinoma, Basal Cell
  • Phoenix, Arizona
  • +70 more
Jun 30, 2022

Basal Cell Nevus Syndrome, Gorlin Syndrome Trial in Oakland, New York (GDC-0449)

Completed
Has Results
  • Basal Cell Nevus Syndrome
  • Gorlin Syndrome
  • Oakland, California
  • +1 more
Dec 16, 2020

Chronic GVHD Trial in Ann Arbor, Salt Lake City (Laboratory Biomarker Analysis, Vismodegib)

Terminated
Has Results
  • Chronic Graft Versus Host Disease
  • Ann Arbor, Michigan
  • +1 more
Jun 22, 2021

NSCLC Trial in Dallas (Itraconazole)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Dallas, Texas
    UT Southwestern Medical Center
Apr 7, 2021

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Palo Alto, California
  • +5 more
Jan 12, 2023

Pancreatic Ductal Adenocarcinoma Trial in Baltimore (LDE225-600mg, Gemcitabine, nab-paclitaxel)

Terminated
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 17, 2020

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage I Prostate Adenocarcinoma AJCC v7 Trial in San Francisco

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 22, 2020

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

A Study of the Genetic Analysis of Brain Disorders

Completed
  • Holoprosencephaly
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 10, 2021

    Interrogation of Wnt, Notch and Hedgehog Activity in Primary

    Terminated
    • Cancer
      • Miami, Florida
        University of Miami
      Mar 28, 2019

      Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Adelaide, South Australia, Australia
        Research Site
      Apr 5, 2023

      Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

      Terminated
      Has Results
      • Pontine Glioma
      • Phoenix, Arizona
      • +1 more
      Apr 20, 2022